1-14 of 14
Bruce Woda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

p53 Immunohistochemistry As a High-Specificity Biomarker to Predict Allelic State and Overall Survival in Myelodysplastic Syndrome or Acute Myeloid Leukemia with Mutated TP53

Shyam Ajay Patel, Salwa Khedr, Caroline D Gordon, Noah Littman, Bruce Woda, Lloyd Hutchinson, Jan Cerny, Shaoguang Li, William Selove, Jonathan M. Gerber
Journal: Blood
Blood (2024) 144 (Supplement 1): 1546.
https://doi.org/10.1182/blood-2024-209416
Published: 2024
Journal Articles

Frameshift Mutations in Leukemia Associated Genes Correlate with Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia Compared to Other Types of Mutations

Emma Camman, Sindha Madhav, Lloyd Hutchinson, Muthalagu Ramanathan, Jan Cerny, Jacob Bledsoe, Bruce Woda, Shyam Ajay Patel, William Selove
Journal: Blood
Blood (2023) 142 (Supplement 1): 6030.
https://doi.org/10.1182/blood-2023-177744
Published: 2023
Journal Articles

Sole DNMT3A/TET2/ASXL1 Mutations Define a Distinct Clinical Trajectory for Patients with Clonal Hematopoiesis

Shyam Ajay Patel, William K Gerber, Rena Zheng, Shrinkhala Khanna, Lloyd Hutchinson, Jan Cerny, Brandon Dasilva, Tian Y. Zhang, Salwa Khedr, William Selove, Bruce Woda, Gregory A Abel, Patricia Minehart Miron, Anne Higgins, Jonathan M. Gerber
Journal: Blood
Blood (2023) 142 (Supplement 1): 4068.
https://doi.org/10.1182/blood-2023-182881
Published: 2023
Journal Articles

Early Identification of TP53 mutation in Myelodysplastic Neoplasms and Acute Myeloid Leukemia Via Point-of-Care p53 Immunohistochemistry

Shyam Ajay Patel, Salwa Khedr, Sri Nuvvula, Bruce Woda, Jan Cerny, William Selove, Lloyd Hutchinson, Jonathan M. Gerber
Journal: Blood
Blood (2023) 142 (Supplement 1): 4333.
https://doi.org/10.1182/blood-2023-182285
Published: 2023
Journal Articles

Clonal Dynamics and Deterministic Clinical Fate Mapping of Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukemia with TP53 Disruption

Shyam Ajay Patel, Benjamin Tanenbaum, Asiri Ediriwickrema, Jan Cerny, Lloyd Hutchinson, Xiuling Meng, William K Gerber, Salwa Khedr, William Selove, Bruce Woda, Jonathan M. Gerber
Journal: Blood
Blood (2023) 142 (Supplement 1): 5915.
https://doi.org/10.1182/blood-2023-181945
Published: 2023
Journal Articles

Natural History of Patients with Clonal Hematopoiesis Seen in Hematology Clinics

Shyam A Patel, William K Gerber, Lloyd Hutchinson, Shrinkhala Khanna, Jan Cerny, Muthalagu Ramanathan, Andrew Gillis-Smith, Sakiko Suzuki, Gregory A. Abel, Salwa Khedr, William Selove, Bruce Woda, Rena Zheng, Patricia Minehart Miron, Anne Higgins, Jonathan M Gerber
Journal: Blood
Blood (2022) 140 (Supplement 1): 5756–5758.
https://doi.org/10.1182/blood-2022-168473
Published: 2022
Journal Articles

Impaired Clearance of DNMT3A/TET2/ASXL1 -Mutant Clones with Hypomethylating Agent or Intensive Induction Chemotherapy for Myelodysplastic Syndrome and Acute Myeloid Leukemia

Shyam A Patel, William K Gerber, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan, Andrew Gillis-Smith, Sakiko Suzuki, Salwa Khedr, Bruce Woda, William Selove, Jonathan M Gerber
Journal: Blood
Blood (2022) 140 (Supplement 1): 9150–9151.
https://doi.org/10.1182/blood-2022-169644
Published: 2022
Journal Articles

High Dose Mitoxantrone Based "5+1" Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

Neeraj Y Saini, MD, Jan Cerny, MD PhD, Vanessa Furtado, MD, Angela Desmond, Zheng Zhou, Glen D. Raffel, MD, Imran Puthawala, Jayde Bednarik, PharmD, Lindsey Shanahan, Patricia Minehart Miron, PhD, Bruce Woda, MD, Muthalagu Ramanathan, MD, Rajneesh Nath, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1430.
https://doi.org/10.1182/blood-2018-99-116857
Published: 2018
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers

Andrew M Evens, DO,MSc, Monika Pilichowska, MD PhD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Hong Chang, PhD, Jennifer A. Kanakry, MD, Laurie H Sehn, Tatyana A Feldman, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Jeremy S. Abramson, MD, Athena Kritharis, MD, Oliver W. Press, MD PhD, Timothy S. Fenske, MD, Jonathan W. Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, MDMPH, Bruce Woda, MD, Randy D. Gascoyne, MD, Elaine S. Jaffe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 375.
https://doi.org/10.1182/blood.V130.Suppl_1.375.375
Published: 2017
Journal Articles

Patient-Derived Xenografts (PDX) of B Cell Lymphoma in NSG Mice: A Mouse Avatar for Developing Personalized Medicine

Rachel Gerstein, PhD, Zheng Zhou, MD PhD, Hong Zhang, PhD, Andrew Evens, DO, MSc, FACP, Nicole Walsh, PhD, Leonard Shultz, Rita Bortell, PhD, Michael Brehm, PhD, Jan Cerny, MD PhD, Giles Whalen, MD, Jack Leonard, PhD, Bruce Woda, MD, Dale Greiner, PhD, Alan G. Rosmarin, MD
Journal: Blood
Blood (2015) 126 (23): 5408.
https://doi.org/10.1182/blood.V126.23.5408.5408
Published: 2015
Journal Articles

Resolving the Biological Heterogeneity of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between DLBCL and BL (BCL-U) Using Quantitative Profiles of Oncogenic Signaling Networks

Christopher Daniel Carey, MD,, Daniel Gusenleitner, MS, Zhang Xuan, BA, Aliyah R Sohani, MD, Olga Weinberg, MD, Hongbo Yu, MD, Ben Chen, MD PhD, Bruce Woda, MD, Kai Fu, MD PhD, Stefano Monti, PhD, Scott J. Rodig, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 3903.
https://doi.org/10.1182/blood.V126.23.3903.3903
Published: 2015
Journal Articles

Survival of Newly Diagnosed T-Cell Lymphoma (TCL) in the Modern Era: Investigation of Prognostic Factors with Critical Examination of Therapy in a Multicenter US Cohort.

Andrew M. Evens, DO, MSc, Tatyana Feldman, MD, Aimee Kroll, MS, Lori S. Muffly, MD, Eric Winer, MD, Christopher Flowers, MD, Frederick Lansigan, MD, Chadi Nabhan, MD, FACP, Loretta Nastoupil, MD, Austin Kim, MD, Xiuning Li, MD, Kathryn Waksmundzki, David Lam, MD, Jacqueline Tessa Draper, BS, Ashley Meilleur, BS, Rajneesh Nath, MD, Peter Cygan, MD, Jorge J Castillo, MD, Andre Goy, MD, Bruce Woda, MD, Sonali M. Smith, MD, Steven T. Rosen, MD, FRCPA, Jeremy S. Abramson, MD
Journal: Blood
Blood (2012) 120 (21): 2728.
https://doi.org/10.1182/blood.V120.21.2728.2728
Published: 2012
Journal Articles

Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT),

Jan Cerny, MD, PhD, Lesley Woods, MD, Hongbo Yu, MD, PhD, Muthalagu Ramanathan, MD, Glen D Raffel, M.D, Ph.D., William V Walsh, MD, Laura J Petrillo-Deluca, PA-C, Natasha M Tarrasky, PA-C, Elizabeth O'Rourke, NP, Jayde L Bednarik, PharmD, Bruce Woda, MD, Lloyd Hutchinson, PhD, Aimee Kroll, MS, Bruce Barton, PhD, Alan G. Rosmarin, MD, Rajneesh Nath, MD
Journal: Blood
Blood (2011) 118 (21): 3560.
https://doi.org/10.1182/blood.V118.21.3560.3560
Published: 2011
Journal Articles

High Complete Remission (CR) Rates and Reduced Early Mortality with High Dose Ara-c (HiDAC) and Mitoxantrone (MITO) Induction Chemotherapy for Older (age>60) High Risk Patients with Acute Myeloid Leukemia (AML)

Muthalagu Ramanathan, MD, Zheng Zhou, MD, Jan Cerny, MD, PhD, Glen D Raffel, M.D, Ph.D., Laura Petrillo-Deluca, William Vincent Walsh, MD, Venu Bathini, MD, Micheal Vail, Karen Smethers, Bruce Woda, MD, Patricia Miron, MD, Alan G. Rosmarin, MD, Rajneesh Nath, MD
Journal: Blood
Blood (2010) 116 (21): 3290.
https://doi.org/10.1182/blood.V116.21.3290.3290
Published: 2010